Pearl Index Study With Low Dose Combined Oral Contraceptive
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the contraceptive efficacy, bleeding pattern, and
safety of SH D00342A. Subjects participating in the study will be treated with an oral
contraceptive pill containing 0.03 mg ethinylestradiol and 0.125 mg levonorgestrel.